oxybutynin has been researched along with ovalbumin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JS; Chen, PC; Hsu, CJ; Lee, SJ; Lin, JY; Liu, CY; Miaw, SC; Wang, LF | 1 |
| Asada, H; Ishii, Y; Kamiyama, F; Matsuo, K; Mukai, Y; Nakagawa, S; Okada, N; Quan, YS | 1 |
| Kamiyama, F; Matsuo, K; Mukai, Y; Nakagawa, S; Okada, N; Quan, YS; Yokota, Y; Zhai, Y | 1 |
| Fernando, GJ; Kendall, MA; Ng, HI | 1 |
| Hiraishi, Y; Hirobe, S; Kamiyama, F; Nakagawa, S; Nakagawa, T; Okada, N; Quan, YS | 1 |
| Kumar, MNK; Wu, MX; Zhou, C | 1 |
| Crichton, ML; Depelsenaire, ACI; Kendall, MAF; Kuo, P; Phipps, S; van der Burg, NMD | 1 |
| Hwang, YH; Jeong, DH; Kang, KY; Kim, HK; Kim, JD; Kim, JJ; Kim, SJ; Lee, HS; Lee, SJ; Paik, MJ; Yee, ST | 1 |
8 other study(ies) available for oxybutynin and ovalbumin
| Article | Year |
|---|---|
Epicutaneous sensitization with protein antigen induces Th9 cells.
Topics: Animals; Antigens; Immunization; Interleukin-9; Mice; Mice, Inbred BALB C; Ovalbumin; T-Lymphocytes, Helper-Inducer; Transdermal Patch | 2012 |
Compositional optimization and safety assessment of a hydrogel patch as a transcutaneous immunization device.
Topics: Administration, Cutaneous; Animals; Antigens; Diphtheria Toxin; Female; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; In Vitro Techniques; Male; Ovalbumin; Rats; Rats, Hairless; Rats, Wistar; Skin; Skin Tests; Tetanus Toxin; Transdermal Patch; Vaccination | 2011 |
A low-invasive and effective transcutaneous immunization system using a novel dissolving microneedle array for soluble and particulate antigens.
Topics: Adenoviridae; Adenoviridae Infections; Administration, Cutaneous; Animals; Antigens; Cell Line; Drug Delivery Systems; Female; Humans; Hyaluronic Acid; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Ovalbumin; Rats; Rats, Wistar; Skin; Transdermal Patch; Vaccination | 2012 |
Induction of potent CD8⁺ T cell responses through the delivery of subunit protein vaccines to skin antigen-presenting cells using densely packed microprojection arrays.
Topics: Adjuvants, Immunologic; Animals; Antigen-Presenting Cells; CD8-Positive T-Lymphocytes; Female; Methylcellulose; Mice; Mice, Inbred C57BL; Nanoparticles; Oligodeoxyribonucleotides; Ovalbumin; Protein Subunits; Quillaja Saponins; Saponins; Skin; Spleen; Transdermal Patch; Vaccination; Vaccines, Subunit | 2012 |
Performance and characteristics evaluation of a sodium hyaluronate-based microneedle patch for a transcutaneous drug delivery system.
Topics: Administration, Cutaneous; Animals; Diphtheria Toxoid; Drug Combinations; Drug Delivery Systems; Drug Stability; Drug Storage; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humidity; Hyaluronic Acid; Mice; Mice, Hairless; Mice, Inbred ICR; Microinjections; Needles; Ovalbumin; Rats; Rats, Wistar; Tetanus Toxoid; Time Factors; Transdermal Patch; Tretinoin | 2013 |
Laser-facilitated epicutaneous immunotherapy to IgE-mediated allergy.
Topics: Administration, Cutaneous; Allergens; Animals; Calcitriol; Cytokines; Desensitization, Immunologic; Female; Immunoglobulin E; Immunoglobulin G; Lasers; Lung; Mice, Inbred BALB C; Oligodeoxyribonucleotides; Ovalbumin; Powders; Respiratory Hypersensitivity; Sirolimus; Skin; T-Lymphocytes, Regulatory; Transdermal Patch | 2016 |
A low inflammatory, Langerhans cell-targeted microprojection patch to deliver ovalbumin to the epidermis of mouse skin.
Topics: Animals; Cell Movement; Cell Survival; Dermis; Drug Carriers; Drug Liberation; Epidermal Cells; Epidermis; Inflammation; Langerhans Cells; Mice; Mice, Inbred BALB C; Models, Theoretical; Ovalbumin; Polycarboxylate Cement; Silicon; Skin; Transdermal Patch | 2019 |
Enhanced anti-tumor immunotherapy by dissolving microneedle patch loaded ovalbumin.
Topics: Administration, Cutaneous; Animals; Antigens; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Proliferation; Drug Delivery Systems; Immunity; Immunotherapy; Mice; Needles; Neoplasms; Ovalbumin; T-Lymphocytes, Cytotoxic; Transdermal Patch; Treatment Outcome | 2019 |